Tumor Promoter Expression May Aid in Lung Cancer Diagnosis

Share this content:

the Cancer Therapy Advisor take:

The leading cause of cancer-related death in the United States is lung cancer. Cancer stem cells (CSCs) have self-renewal and tumorigenic properties, and advances in technology suggest their existence in various human tumors. CSCs may play a major role in tumor development and progression due to their role in stimulating carcinogenesis. Various chemical and environmental factors, such as heavy metals, cigarette smoke, and air pollution, affect carcinogenesis induction. According to a study published in Oncotarget, researchers studied how exposure to carbon nanotubes (CNTs), which constitute one of the most frequently produced nanomaterials, affects CSC regulation. Yon Rojanasakul and researchers exposed human lung epithelial cells to single-walled (SW) CNTs for 6 months in a workplace-relevant setting. Results indicated that this chronic SW-CNT exposure caused an emergence of lung CSCs, and these CSCs overexpressed the tumor promoter caveolin-1 (Cav-1). It has been found in a previous study that Cav-1 positivity was associated with poor prognosis and survival in patients with lung cancer. Consequently, the CSCs in the current study were resistant to apoptosis, or cell death, and displayed increased cell invasion and migration. Through this study, researchers found Cav-1’s role in CSC regulation and SW-CNT transformed cell regulation, which could prove useful for the diagnosis and prognosis of lung cancer.

Tumor Promoter Expression May Aid in Lung Cancer Diagnosis
Tumor Promoter Expression May Aid in Lung Cancer Diagnosis
Cancer stem cells (CSCs) may represent targets for carcinogenic initiation by chemical and environmental agents. These CSCs, which were found to overexpress tumor promoter caveolin-1 (Cav-1), displayed aggressive cancer phenotypes of apoptosis resistance and enhanced cell invasion and migration compared with their non-CSC counterpart.
READ FULL ARTICLE From National Institute of Health

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs